Comoros vs Guyana: Access to anti-retroviral drugs, female
Comoros
74.0%
in 2024
Guyana
75.0%
in 2024
Comoros rank
69th
Guyana rank
67th
Access to anti-retroviral drugs, female over time
- Comoros
- Guyana
How they compare
Guyana currently reports 75.0% against 74.0% in Comoros, a difference of 1.0%.
The two have swapped places 2 times across 25 shared years of data; in 2000 it was Guyana ahead.
Comoros ranks 69th and Guyana ranks 67th of 141 countries.
Guyana has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Comoros | Guyana | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 0.0% | 20.9% | 20.9% | Guyana |
| 2010s | 42.4% | 66.6% | 24.2% | Guyana |
| 2020s | 70.2% | 72.6% | 2.4% | Guyana |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, female, Comoros or Guyana?
- Guyana, at 75.0% against 74.0% in Comoros as of 2024.
- What is the difference in access to anti-retroviral drugs, female between Comoros and Guyana?
- 1.0%, with Guyana ahead.
- How many years of comparable data are there for Comoros and Guyana?
- 25 years are reported by both, from 2000 to 2024.
- How do Comoros and Guyana rank globally for access to anti-retroviral drugs, female?
- Comoros ranks 69th and Guyana ranks 67th of 141 countries.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, female (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult females living with HIV who are receiving antiretroviral therapy.